CytoSorbents Corporation (CTSO)

[Lakersrback]

Management should be left alone! In my opinion they've done a wonderful job of building shareholder value and more importantly growing revenue. The real problem is the lack of RCT efficacy data. I have always maintained it is the biggest problem here. Hoping this new trial turns out to be the right fit for the product and subsequently shareholders. Blaming management is kind of juvenile and in many ways sounds like an excuse. If people keep doing this is gives the story itself more hope. The blood runs through the filter, the management can only take to the FDA the product in hand. Let us see where the new endeavor takes us with the FDA. Best of luck to all shareholders and great job from management given our lack of RCT data to really get this product moving with big pharma and distribution. Just my 2 cents and looking forward to data from the new trial!